150
Views
3
CrossRef citations to date
0
Altmetric
Articles

Provisions for Health Sector Response to Substance Use Disorders in the Indian Policy: A Critique of the National Policy on Narcotic Drugs and Psychotropic Substances

, MD, DNB, MSc, MNAMSORCID Icon & , MD, DM
Pages 93-100 | Received 29 Aug 2019, Accepted 13 Dec 2019, Published online: 02 Jan 2020

References

  • Balhara, Y., A. Parmar, S. Sarkar, and R. Verma. 2016a. Stigma in dual diagnosis: A narrative review. Indian Journal of Social Psychiatry 32:128–33. doi:10.4103/0971-9962.181093.
  • Balhara, Y., S. Sarkar, S. Bera, R. Gupta, N. Chawla, and R. Lal. 2016b. Who seeks treatment for dual disorders? Observations from a dual disorder clinic at the national drug dependence treatment centre in India over a 12 year period. International Journal of High Risk Behaviors and Addiction 6 (1):e32501.
  • Broyles, L. M., I. A. Binswanger, J. A. Jenkins, D. S. Finnell, B. Faseru, A. Cavaiola, M. Pugatch, and A. J. Gordon. 2014. Confronting inadvertent stigma and pejorative language in addiction scholarship: A recognition and response. Substance Abuse 35 (3):217–21. doi:10.1080/08897077.2014.930372.
  • Commission, I.-A. D.-A. C. 2009. How to develop a national drug policy: A guide for policymakers, practitioners, and stakeholders: Organization of American States (OAS), Inter-American drug abuse control commission (CICAD), Caribbean community (CARICOM) secretariat. OAS Cataloguing-in-Publication Data.
  • Csete, J., A. Kamarulzaman, M. Kazatchkine, F. Altice, M. Balicki, J. Buxton, J. Cepeda, M. Comfort, E. Goosby, J. Goulao, et al. 2016. Public health and international drug policy. Lancet 387 (10026):1427–80. doi:10.1016/S0140-6736(16)00619-X.
  • Degenhardt, L., M. Glantz, S. Evans-Lacko, E. Sadikova, N. Sampson, G. Thornicroft, S. Aguilar-Gaxiola, A. Al-Hamzawi, J. Alonso, L. Helena Andrade, et al.; World Health Organization’s World Mental Health Surveys, c. 2017. Estimating treatment coverage for people with substance use disorders: An analysis of data from the world mental health surveys. World Psychiatry 16 (3):299–307. doi:10.1002/wps.20457.
  • Department of Health, Australia. n.d. Ministerial drug and alcohol forum. https://www.health.gov.au/committees-and-groups/ministerial-drug-and-alcohol-forum-mdaf?utm_source=nationalstrategy.gov.au&utm_medium=redirect&utm_campaign=digital_transformation.
  • EMCDDA. 2011. European drug prevention quality standards. Lisbon, Portugal: European Monitoring Centre on Drugs and Drug Addiction.
  • EMCDDA. 2013. Drug policy and law: The European monitoring centre for drugs and drug addiction. EMCDDA.
  • EMCDDA. 2017. Evaluating drug policy: A seven-step guide to support the commissioning and managing of evaluations. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction.
  • European Commission. 2012. EU drugs strategy (2013-2020). Brussels: European Commission. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2012:402:0001:0010:en:PDF
  • GOI, D. 2019. National policy on NDPS: Department of revenue, minsitry of finance, governemt of India. Government of India.
  • Jhanjee, S., R. Jain, and H. Sethi. n.d. Rolling out of opioid substitution treatment (OST) in Tihar Prisons, India: A collaborative project of UNODC- ROSA, AIIMS & Tihar Prisons. India: United Nations publication.
  • Jhanjee, S., S. Pant, N. K. Girdhar, H. Sethi, R. Gunasekaran Rengaswamy, R. Jain, and J. Sarangi. 2015. Opioid substitution treatment in Tihar prisons, India: Process of implementation. International Journal of Drug Policy 26 (9):890–91.
  • MSJE. n.d. Implementation framework of national action plan for drug demand reduction. Ministry of Social Justice and Empowerment, Government of India.
  • Murthy, P., N. Manjunatha, B. N. Subodh, P. K. Chand, and V. Benegal. 2010. Substance use and addiction research in India. Indian Journal of Psychiatry 52 (Suppl 1):S189–99. doi:10.4103/0019-5545.69232.
  • National Alliance to End Homelessness. 2009. National recommended best practices for serving LGBT homeless youth. Washington, DC. http://www.endhomelessness.org/library/entry/national-recommended-best-practices-for-serving-lgbt-homeless-youth.
  • Sarin, E., L. Samson, M. Sweat, and C. Beyrer. 2011. Human rights abuses and suicidal ideation among male injecting drug users in Delhi, India. International Journal of Drug Policy 22 (2):161–66. doi:10.1016/j.drugpo.2010.09.011.
  • Schuckit, M. A. 2016. Treatment of opioid-use disorders. New England Journal of Medicine 375 (4):357–68. doi:10.1056/NEJMra1604339.
  • Singh, S., Y. P. S. Balhara, P. Gupta, and N. Christodoulou. Under publication. Primary and secondary prevention strategies against illicit drug use among adults aged 18-25: A narrative review. Australasian Psychiatry; 1-7.
  • Soper, M. H., R. Matulis, and C. Menschner. 2017. Moving toward value-based payment for medicaid behavioral health services. Center for Health Care Strategies.
  • UN. 2016. Outcome document of the 2016 United Nations general assembly special session on the world drug problem. Geneva, United Nations.
  • UNDP. 2019. International guidelines on human rights and drug policy | UNDP. [online]. Accessed December 6, 2019. https://www.undp.org/content/undp/en/home/librarypage/hiv-aids/international-guidelines-on-human-rights-and-drug-policy.html.
  • United Nations General Assembly. 2016. United Nations standard minimum rules for the treatment of prisoners (the Nelson Mandela Rules) (UN Doc. A/RES/70/175). New York, NY: United Nations. https://www.unodc.org/pdf/criminal_justice/UN_Standard_Minimum_Rules_for_the_Treatment_of_Prisoners.pdf.
  • UNODC. 2015. International standards on drug use prevention. Geneva, United Nations.
  • UNODC-WHO. 2017. International standards for the treatment of drug use disorders. Geneva, United Nations.
  • Whiteford, H. A., L. Degenhardt, J. Rehm, A. J. Baxter, A. J. Ferrari, H. E. Erskine, F. J. Charlson, R. E. Norman, A. D. Flaxman, N. Johns, et al. 2013. Global burden of disease attributable to mental and substance use disorders: Findings from the global burden of disease study 2010. Lancet 382 (9904):1575–86. doi:10.1016/S0140-6736(13)61611-6.
  • WHO. 2019. Health policy. World Health Organization.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.